Skip to main content

Table 2 Characteristics, risk factors, and diagnostic and therapeutic procedures for myocardial infarction admissions in type 2 diabetes mellitus (T2DM) versus non-diabetic patients, according to year of study (2002, 2006, 2010, and 2014)

From: Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014)

 

2002

2006

2010

2014

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

N (%)

12,217 (100)

12,217 (100)

NA

13,013 (100)

13,013 (100)

NA

12,739 (100)

12,739 (100)

NA

12,458 (100)

12,458 (100)

NA

Age adjusted rate per 100.000 inhabitantsa

63.69

NA

NA

61.97

NA

NA

55.86

NA

NA

51.07

NA

NA

Male sex, n (%)a,b

7757 (63.49)

7757 (63.49)

NA

8855 (68.05)

8855 (68.05)

NA

8892 (69.8)

8892 (69.8)

NA

8819 (70.79)

8819 (70.79)

NA

Age, mean (SD)a,b

71.01 (10.73)

71.01 (10.73)

NA

70.87 (11.49)

70.87 (11.49)

NA

70.5 (12.05)

70.5 (12.05)

NA

70.23 (12.36)

70.23 (12.36)

NA

40–59 years, n (%)

1965 (16.08)

1965 (16.08)

NA

2411 (18.53)

2411 (18.53)

NA

2642 (20.74)

2642 (20.74)

NA

2775 (22.27)

2775 (22.27)

NA

60–69 years, n (%)

2927 (23.96)

2927 (23.96)

2845 (21.86)

2845 (21.86)

2957 (23.21)

2957 (23.21)

3022 (24.26)

3022 (24.26)

70–79 years, n (%)

4559 (37.32)

4559 (37.32)

4448 (34.18)

4448 (34.18)

3764 (29.55)

3764 (29.55)

3217 (25.82)

3217 (25.82)

≥ 80 years, n (%)

2766 (22.64)

2766 (22.64)

3309 (25.43)

3309 (25.43)

3376 (26.5)

3376 (26.5)

3444 (27.64)

3444 (27.64)

CCI, mean (SD)a,b

2.65 (0.82)

1.52 (0.74)

< 0.01

2.7 (0.88)

1.56 (0.8)

< 0.01

2.76 (0.9)

1.58 (0.82)

< 0.01

2.8 (0.92)

1.62 (0.85)

< 0.01

Smoking, n (%)a,b

2938 (24.05)

3275 (26.81)

< 0.01

4116 (31.63)

4593 (35.3)

< 0.01

4566 (35.84)

5258 (41.27)

< 0.01

4773 (38.31)

5536 (44.44)

< 0.01

Obesity, n (%)a,b

1019 (8.34)

565 (4.62)

< 0.01

1488 (11.43)

831 (6.39)

< 0.01

1991 (15.63)

1130 (8.87)

< 0.01

2238 (17.96)

1275 (10.23)

< 0.01

Hypertension, n (%)a,b

6047 (49.5)

4687 (38.36)

< 0.01

7511 (57.72)

6038 (46.4)

< 0.01

7576 (59.47)

5954 (46.74)

< 0.01

7401 (59.41)

5938 (47.66)

< 0.01

Lipid metabolism disorders, n (%)a,b

1518 (12.43)

1118 (9.15)

< 0.01

2940 (22.59)

2187 (16.81)

< 0.01

4794 (37.63)

3592 (28.2)

< 0.01

5715 (45.87)

4019 (32.26)

< 0.01

Renal diseases, n (%)a,b

974 (7.97)

604 (4.94)

< 0.01

1355 (10.41)

853 (6.55)

< 0.01

1755 (13.78)

1031 (8.09)

< 0.01

2034 (16.33)

1287 (10.33)

< 0.01

Atrial fibrillation, n (%)a,b

1445 (11.83)

1574 (12.88)

0.011

1592 (12.23)

1707 (13.12)

0.029

1673 (13.13)

1689 (13.26)

0.760

1779 (14.28)

1800 (14.45)

0.697

CHF, n (%)a

2842 (23.26)

2263 (18.52)

< 0.01

3125 (24.01)

2357 (18.11)

< 0.01

3175 (24.92)

2307 (18.11)

< 0.01

3171 (25.45)

2331 (18.71)

< 0.01

Mechanical ventilation, n (%)a

559 (4.58)

504 (4.13)

0.082

519 (3.99)

484 (3.72)

0.259

445 (3.49)

514 (4.03)

0.022

448 (3.6)

446 (3.58)

0.070

HD/DP, n (%)a

83 (0.68)

69 (0.56)

0.257

160 (1.23)

86 (0.66)

< 0.01

172 (1.35)

85 (0.67)

< 0.01

182 (1.46)

95 (0.76)

< 0.01

CABG, n (%)

220 (1.8)

219 (1.79)

0.961

224 (1.72)

210 (1.61)

0.495

246 (1.93)

233 (1.83)

0.547

236 (1.89)

204 (1.64)

0.127

PCI, n (%)a,b

2038 (16.68)

2357 (19.29)

< 0.01

4172 (32.06)

4586 (35.24)

< 0.01

5677 (44.56)

6097 (47.86)

< 0.01

6643 (53.32)

7096 (56.96)

< 0.01

Fibrinolysis, n (%)a,b

1613 (13.2)

1694 (13.87)

0.109

1289 (9.91)

1451 (11.15)

0.001

906 (7.11)

1048 (8.23)

0.001

463 (3.72)

567 (4.55)

0.001

LHS, mean (SD)a,b

10.59 (9.14)

10.08 (9.45)

< 0.01

9.62 (8.7)

8.82 (8.28)

< 0.01

8.47 (9.23)

8.17 (11.51)

0.021

7.58 (7.18)

7.17 (7.86)

< 0.01

In-hospital mortality, n (%)a,b

1670 (13.67)

1418 (11.61)

< 0.01

1409 (10.83)

1234 (9.48)

< 0.01

1209 (9.49)

1097 (8.61)

0.011

991 (7.95)

899 (7.22)

0.022

  1. CCI charlson comorbidity index, CHF congestive heart failure, HD/DP hemodyalisis/peritoneal dialysis, CABG coronary artery bypass graft, PCI percutaneous coronary intervention, LHS length of hospital stay
  2. aSignificant time trend among T2DM sufferers
  3. bSignificant time trend among non-T2DM sufferers